Red Light Holland expands psilocybin supply deal with Allu Therapeutics, adding GMP microdose PEX010.

Red Light Holland has expanded its supply agreement with Allu Therapeutics to include Filament Health's GMP-compliant botanical psilocybin drug candidate, PEX010, in a standardized microdose format. This marks the first GMP-compliant standardized microdose botanical psilocybin product, enhancing regulated access and research in New Zealand, where psilocybin prescriptions are allowed for treatment-resistant patients. The deal leverages Filament Health's acquisition to boost pharmaceutical-grade production and clinical research capabilities, supporting broader medicinal use and regulatory-compliant supply pathways globally.